E Fund Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190K | Buy |
13,612
+1,543
| +13% | +$21.6K | 0.01% | 363 |
|
|
2025
Q1 | $164K | Buy |
12,069
+2,072
| +21% | +$28.2K | 0.01% | 372 |
|
|
2024
Q4 | $204K | Buy |
9,997
+2,436
| +32% | +$49.6K | 0.01% | 363 |
|
|
2024
Q3 | $220K | Sell |
7,561
-1,639
| -18% | -$47.7K | 0.01% | 308 |
|
|
2024
Q2 | $214K | Sell |
9,200
-11,352
| -55% | -$264K | 0.01% | 278 |
|
|
2024
Q1 | $422K | Buy |
20,552
+3,262
| +19% | +$66.9K | 0.03% | 197 |
|
|
2023
Q4 | $371K | Buy |
17,290
+5,509
| +47% | +$118K | 0.02% | 202 |
|
|
2023
Q3 | $243K | Sell |
11,781
-1,580
| -12% | -$32.6K | 0.02% | 229 |
|
|
2023
Q2 | $394K | Sell |
13,361
-1,258
| -9% | -$37.1K | 0.03% | 175 |
|
|
2023
Q1 | $337K | Sell |
14,619
-242
| -2% | -$5.58K | 0.02% | 210 |
|
|
2022
Q4 | $413K | Buy |
14,861
+607
| +4% | +$16.9K | 0.03% | 174 |
|
|
2022
Q3 | $437K | Buy |
14,254
+2,613
| +22% | +$80.1K | 0.04% | 159 |
|
|
2022
Q2 | $343K | Buy |
11,641
+2,814
| +32% | +$82.9K | 0.03% | 210 |
|
|
2022
Q1 | $284K | Buy |
+8,827
| New | +$284K | 0.01% | 214 |
|